Literature DB >> 10024248

Difficult asthma or Churg-Strauss syndrome?

D P D'Cruz, N C Barnes, C M Lockwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10024248      PMCID： PMC1114944          DOI： 10.1136/bmj.318.7182.475

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced vasculitides.

Authors:  J J Dubost; P Souteyrand; B Sauvezie
Journal:  Baillieres Clin Rheumatol       Date:  1991-04

2.  Joint pains, sinusitis, wheezing and mild vasculitis--a distinct syndrome?

Authors:  G V Hughes; D D'Cruz
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

3.  Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.

Authors:  A Sampson; S Holgate
Journal:  BMJ       Date:  1998-04-25

4.  Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast.

Authors:  M E Wechsler; E Garpestad; S R Flier; O Kocher; D A Weiland; A J Polito; M M Klinek; T D Bigby; G A Wong; R A Helmers; J M Drazen
Journal:  JAMA       Date:  1998-02-11       Impact factor: 56.272

5.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

Review 6.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

7.  Allergic disorders in systemic vasculitis: a case-controlled study.

Authors:  M J Cuadrado; D D'Cruz; M Lloyd; F Mujic; M A Khamashta; G R Hughes
Journal:  Br J Rheumatol       Date:  1994-08

8.  Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome).

Authors:  K D Olsen; H B Neel; R A Deremee; L H Weiland
Journal:  Otolaryngol Head Neck Surg (1979)       Date:  1980 Jan-Feb

9.  Formes frustes of Churg-Strauss syndrome.

Authors:  A Churg; M Brallas; S R Cronin; J Churg
Journal:  Chest       Date:  1995-08       Impact factor: 9.410
  9 in total
  11 in total

Review 1.  Leukotriene receptor antagonist therapy.

Authors:  O J Dempsey
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Wegener's granulomatosis and the Churg-Strauss syndrome.

Authors:  J L Faul; W G Kuschner
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

Review 3.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Authors:  Richard B R Muijsers; Stuart Noble
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

6.  Montelukast. No current use for asthma.

Authors: 
Journal:  Can Fam Physician       Date:  2000-01       Impact factor: 3.275

7.  Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

Authors:  M E Wechsler; R Pauwels; J M Drazen
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

8.  Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.

Authors:  Ebru Dirikgil; Sander W Tas; Cornelis A Verburgh; Darius Soonawala; A Elisabeth Hak; Hilde H F Remmelts; Daphne IJpelaar; Gozewijn D Laverman; Abraham Rutgers; Jaap M van Laar; Hein J Bernelot Moens; Peter M J Verhoeven; Ton J Rabelink; Willem Jan W Bos; Y K Onno Teng
Journal:  Rheumatol Adv Pract       Date:  2022-06-09

9.  Asthma medications: basic pharmacology and use in the athlete.

Authors:  J E Houglum
Journal:  J Athl Train       Date:  2000-04       Impact factor: 2.860

Review 10.  Clinical aspects of primary vasculitis.

Authors:  C A Stegeman; C G Kallenberg
Journal:  Springer Semin Immunopathol       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.